Cocrystal pharma to present at virtual noblecon17 conference on january 19, 2021

Bothell, wash., jan. 12, 2021 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp), (“cocrystal” or the “company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces that management will present at noblecon17, noble capital markets' 17th annual investor conference on tuesday, january 19, 2021 at 2:15 p.m. eastern time (11:15 a.m. pacific time).
COCP Ratings Summary
COCP Quant Ranking